NEOGENOMICS INC — Director's Dealing 2023

May 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-05-11

Reporting Person: Sikri Vishal (President Advanced Diagnostics)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-11	Stock Option (Right to Buy)	$19.65	A	39683	Acquired	2030-05-11	Common Stock (39683.0)	Direct
2023-05-11	Restricted Stock Unit	$0.0	A	21204	Acquired		Common Stock (21204.0)	Direct
2023-05-11	Performance Stock Unit	$0.0	A	21204	Acquired		Common Stock (21204.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	149122	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$8.42	2029-06-01	Common Stock (319112.0)	319112	Direct

Footnotes

F1: This balance includes 442 shares that were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.

F2: On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date.

F3: On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F4: On May 11, 2023, Mr. Sikri was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On May 11, 2023, Mr. Sikri was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

F6: Once vested, the shares of common stock are not subject to expiration.

F7: On May 11, 2023, Mr. Sikri was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.